Advertisement

The Indian Journal of Pediatrics

, Volume 28, Issue 11, pp 460–462 | Cite as

Acetazolamide in the treatment of sickle cell anemia

  • M. K. Khandelwal
Article
  • 69 Downloads

Summary and Conclusion

Acetazolamide was tried in a dosage of 7 mg. per kg. of body weight in 8 cases of sickle cell anemia in the hope that as a potent carbonic anhydrase inhibitor it will prevent deoxygenation of the haemoglobin, intravascular thrombosis and subsequent destruction of the red cells. Sodium bicarbonate and potassium chloride were given to all the cases as well, to prevent metabolic acidosis and hypokalemia. The therapy not only did not produce any beneficial effect and prevent a hemolytic crisis, but possibly even produced increased destruction of the red cells so that three of the cases became very severely anemic during the course of the therapy and expired. Acetazolamide is thus not suitable for treatment of cases of sickle cell anemia.

Keywords

Sickle Cell Anemia Sickle Cell Metabolic Acidosis Acetazolamide Potassium Chloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Charmot, G. andReynaud, R.—Quoted bySantos andLehmann.Google Scholar
  2. 2.
    Conley, J. R., Martin, M. B. andRecinos, A. Jr.—Quoted bySpregue andPaterson.Google Scholar
  3. 3.
    Edington, G. M.B. M. J.,2: 957, 1953.Google Scholar
  4. 4.
    Ferguson, A. D., Carrington, H. T. andScott, R. B.—Quoted bySpregue andPaterson.Google Scholar
  5. 5.
    Grek, I. J. andFindlay, M.—Quoted byEdington.Google Scholar
  6. 6.
    Griffiths, F. E. D.Lancet,2: 20, 1955.CrossRefGoogle Scholar
  7. 7.
    Hilkovitz, G.B. M. J.,2: 266, 1957.CrossRefGoogle Scholar
  8. 8.
    Hughes, J. G., Diggs, L. W. andGillespie, C. E.—Quoted byEdington.Google Scholar
  9. 9.
    Josephs, H. W.—Quoted byEdington.Google Scholar
  10. 10.
    Leivy, F. E. andSchnabel, T. G.—Quoted byEdington.Google Scholar
  11. 11.
    MacDougall, L. G. andJacob, G.B.M.J.,2: 141, 1959.Google Scholar
  12. 12.
    Murphy, R. C. andShapiro, S.—Quoted byEdington.Google Scholar
  13. 13.
    Santos, W. D. Dos andLehmann, H.B.M.J.,2: 139, 1959.Google Scholar
  14. 14.
    Shotton, D., Crockett, C. L. Jr. andLeavell, B. S.—Quoted bySpregue andPaterson.Google Scholar
  15. 15.
    Spregue, C. C. andPaterson, J. C. S.Blood,13: 569, 1958.Google Scholar
  16. 16.
    Stohlman, F. Jr. andRath, C. E.Blood, (Abstract),10: 870, 1955.Google Scholar
  17. 17.
    Torrance, E. G. andSchnabel, T. G.—Quoted byEdington.Google Scholar
  18. 18.
    Watson, R. J., Lichtman, H. C. andShapiro, H. D.Amer. Jour. Med.,20: 196, 1956.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1961

Authors and Affiliations

  • M. K. Khandelwal
    • 1
  1. 1.Nagpur

Personalised recommendations